ATOSSA THERAPEUTICS INC (ATOS) Stock Income Statement
NASDAQ:ATOS - Nasdaq - US04962H5063 - Common Stock - Currency: USD
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | N/A | N/A | N/A | N/A | N/A | |||
| Gross Profit | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 29.99M | 27.62M | 31.38M | 27.69M | 20.52M | |||
| Research and Development | 16.47M | 14.12M | 17.33M | 15.08M | 9.21M | |||
| Selling, General, and Administrative Expenses | 13.52M | 13.50M | 14.04M | 12.61M | 11.31M | |||
| Operating Income | -29.99M | -27.62M | -31.38M | -27.69M | -20.52M | |||
| Interest Income/Expense | 3.20M | 4.05M | 4.34M | 760.00K | N/A | |||
| Other Income/Expense | -221.00K | -223.00K | -70.00K | -20.00K | -90.00K | |||
| Non Recurring Items | N/A | -1.71M | -2.99M | N/A | N/A | |||
| Income Before Taxes | -28.72M | -25.50M | -30.09M | -26.96M | -20.61M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -28.72M | -25.50M | -30.09M | -26.96M | -20.61M | |||
| EBITDA | -29.97M | -27.60M | -31.35M | -27.68M | -20.50M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.22 | -0.20 | -0.24 | -0.21 | -0.18 | |||
| Non GAAP EPS | -0.23 | -0.21 | -0.27 | -0.21 | -0.18 | |||
| Statistics | ||||||||
All data in USD